After HHS Secretary Robert F. Kennedy Jr. hosted a roundtable on reducing regulations on stem cells earlier this month, ...

Adult stem cell products could be lining up to penetrate the inflammation and orthopedics markets, judging by the recent $1.38 billion paid by Genzyme for Osiris's mesenchymal stem cell technology.

Stem cells are multipotent cells with the ability to self-renew ... Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and antibody ...

The Drug-Controller General of India (DCGI) has given the go-ahead for the first clinical trials designed to test stem cell products. Stempeutics Research of Bangalore launched a combined phase 1 ...

Still, there is a lot of room for further advancements, and plenty of lab work still needs to be done before stem cell products can be used as cell-based therapies or regenerative medicines.

International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.09 and traded as ...

A sentencing hearing set for Monday has been delayed for one week for an Orange County man who ran a company that marketed unapproved stem cell-based products linked to multiple hospitalizations.

Doctors and clinics nationwide can now purchase these umbilical cord stem cell and exosome products for research, trials, and studies from Adia Labs. For pricing and further information ...